GNA13 and neoplasm: In contrast, injection with 5 × 105 NCC-HN43 cells that stably express either shRNA-control or shRNA-GNA13 in NOD/SCID mice showed a significant reduction in tumor sizes in GNA13-knockdowns as compared to controls (Fig. 3h).